Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Becton Dickinson and Co BDX

Becton, Dickinson and Company is a global medical technology company. The Company is engaged in the development, manufacture and sale of a range of medical supplies, devices, laboratory equipment and diagnostic products used by healthcare institutions, physicians, life science researchers, and others. The Company's BD Medical segment produces an array of medical technologies and devices that are used to help improve healthcare delivery in a wide range of settings. The BD Medical segment consists of various business units, including medication delivery solutions, medication management solutions, and pharmaceutical systems. The Company's BD Life Sciences segment provides products for the collection and transport of diagnostics specimens, and instruments and reagent systems to detect a broad range of infectious diseases, healthcare-associated infections and cancers. The Company's BD Interventional segment provides vascular, urology, oncology and surgical specialty products.


NYSE:BDX - Post by User

Post by edwardebreen15on Aug 19, 2022 6:10am
171 Views
Post# 34906634

Angioplasty Balloons Market Size, Share and Analysis 2022-27

Angioplasty Balloons Market Size, Share and Analysis 2022-27

According to IMARC Group’s latest report, titled Angioplasty Balloons Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027”, the global angioplasty balloons market size reached US$ 2.3 Billion in 2021. Angioplasty balloons are inflated tipped catheters that are used to increase the flow of blood to the heart. These balloons are manufactured from materials such as nylon, polyurethane, and silicone urethane polymers and are available in normal, drug-eluting, scoring, and cutting balloon form. In recent years, angioplasty balloons have gained traction as they facilitate healthcare professionals and doctors to perform surgical procedures and open up the clogged blood vessel during an angioplasty procedure.

 

Request for a PDF sample of this report: https://www.imarcgroup.com/angioplasty-balloons-market/requestsample

 

The global angioplasty balloons market is primarily driven by the rising instances of obesity and high cholesterol levels. Besides this, the increasing use of angioplasty balloons in treating coronary and periphery artery diseases is also fueling market growth. In addition to this, the growing consciousness regarding minimally invasive (MI) procedures among people has increased the demand for drug-coated angioplasty balloons offering enhanced safety, effectiveness, and improved blood flow throughout the body. As a result, healthcare professionals increasingly prefer angioplasty balloons to treat artery disorders. Furthermore, research and development (R&D) activities in the field of medical science coupled with technological advancements, such as the introduction of imaging technology and angioplasty balloons that can be implanted without administering anesthesia, are also creating a positive outlook for the market. Looking forward, IMARC Group expects the global angioplasty balloons market to reach US$ 2.8 Billion by 2027, exhibiting a growth rate (CAGR) of 3.4% during 2022-2027.

 

Checkout Now: https://www.imarcgroup.com/checkout?id=2270&method=1

 

As the novel coronavirus (COVID-19) crisis takes over the world, we are continuously tracking the changes in the markets, as well as the industry behaviors of the consumers globally and our estimates about the latest market trends and forecasts are being done after considering the impact of this pandemic.

 

Competitive Landscape with Key Players:

  • Abbott Laboratories
  • Braun Melsungen AG
  • BD (Becton, Dickinson, and Company)
  • Biotronik SE & Co. KG
  • Boston Scientific Corporation
  • Cardinal Health Inc.
  • Cook Medical LLC
  • Endocor GmbH & Co. KG
  • Johnson & Johnson
  • Medtronic Inc.
  • Terumo Corporation

Market Segmentation:

 

Breakup by Product Type:

  • Normal Balloons
  • Cutting Balloons
  • Drug Eluting Balloons
  • Scoring Balloons

Breakup by Application:

  • Coronary Angioplasty
  • Peripheral Angioplasty

Breakup by Material:

  • Nylon
  • Polyurethane
  • Silicone Urethane Co-Polymers
  • Others

Breakup by End-User:

  • Hospitals
  • Ambulatory Surgery Centers
  • Others

Breakup by Region:

  • North America
    • United States
    • Canada
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Others
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Others
  • Latin America
    • Brazil
    • Mexico
    • Others
  • Middle East and Africa

Ask Analyst for Customization and Explore full report with TOC & List of Figureshttps://www.imarcgroup.com/angioplasty-balloons-market

 

Key highlights of the report:                                                    

  • Market Performance (2016-2021)
  • Market Outlook (2022-2027)
  • Market Trends
  • Market Drivers and Success Factors
  • Impact of COVID-19
  • Value Chain Analysis
  • Comprehensive mapping of the competitive landscape

If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.

 

Related Reports by IMARC Group:

Minimally Invasive Surgery Market: https://www.imarcgroup.com/minimally-invasive-surgery-market

Dental Implants Market: https://www.imarcgroup.com/dental-implants-market

Healthcare It Market: https://www.imarcgroup.com/healthcare-it-market

Blood Pressure Monitoring Devices Market: https://www.imarcgroup.com/blood-pressure-monitoring-devices-market

Home Fitness Equipment Market: https://www.imarcgroup.com/home-fitness-equipment-market

 

About Us:

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

 

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

 

Contact Us:

IMARC Group

30 N Gould St Ste R

Sheridan, WY 82801 USA - Wyoming

Email: Sales@imarcgroup.com

Tel No:(D) +91 120 433 0800

Americas: - +1 631 791 1145 | Africa and Europe: - +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800

<< Previous
Bullboard Posts
Next >>